These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 19146486)
1. Analysis of the survival of Venezuelan equine encephalomyelitis virus and possible viral simulants in liquid suspensions. Fitzgibbon JE; Sagripanti JL J Appl Microbiol; 2008 Nov; 105(5):1477-83. PubMed ID: 19146486 [TBL] [Abstract][Full Text] [Related]
2. Pathogenicity of a Venezuelan equine encephalomyelitis serotype IE virus isolate for ponies. Sahu SP; Pedersen DD; Jenny AL; Schmitt BJ; Alstad AD Am J Trop Med Hyg; 2003 Apr; 68(4):485-94. PubMed ID: 12875302 [TBL] [Abstract][Full Text] [Related]
3. Cross-protective immunity between equine encephalomyelitis viruses in equids. Walton TE; Jochim MM; Barber TL; Thompson LH Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875 [TBL] [Abstract][Full Text] [Related]
4. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis. Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598 [TBL] [Abstract][Full Text] [Related]
5. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines. Ferguson JA; Reeves WC; Hardy JL Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275 [TBL] [Abstract][Full Text] [Related]
6. Radial haemolysis in gel used in serological studies on Venezuelan equine encephalomyelitis virus. Gaidamovich SY; Melnikova EE; Obukhova VR Acta Virol; 1981 Jan; 25(1):36-40. PubMed ID: 6112864 [TBL] [Abstract][Full Text] [Related]
7. Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study. Baker EF; Sasso DR; Maness K; Prichard WD; Parker RL Am J Vet Res; 1978 Oct; 39(10):1627-31. PubMed ID: 717877 [TBL] [Abstract][Full Text] [Related]
8. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110 [TBL] [Abstract][Full Text] [Related]
9. Tunicamycin enhances neuroinvasion and encephalitis in mice infected with Venezuelan equine encephalitis virus. Steele KE; Seth P; Catlin-Lebaron KM; Schoneboom BA; Husain MM; Grieder F; Maheshwari RK Vet Pathol; 2006 Nov; 43(6):904-13. PubMed ID: 17099147 [TBL] [Abstract][Full Text] [Related]
10. Melatonin decreases nitric oxide production and lipid peroxidation and increases interleukin-1 beta in the brain of mice infected by the Venezuelan equine encephalomyelitis virus. Valero N; MarinaEspina L; Bonilla E; Mosquera J J Pineal Res; 2007 Mar; 42(2):107-12. PubMed ID: 17286740 [TBL] [Abstract][Full Text] [Related]
11. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone. Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; Añez F Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268 [TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Charles PC; Trgovcich J; Davis NL; Johnston RE Virology; 2001 Jun; 284(2):190-202. PubMed ID: 11384219 [TBL] [Abstract][Full Text] [Related]
13. Association of Tonate virus (subtype IIIB of the Venezuelan equine encephalitis complex) with encephalitis in a human. Hommel D; Heraud JM; Hulin A; Talarmin A Clin Infect Dis; 2000 Jan; 30(1):188-90. PubMed ID: 10619752 [TBL] [Abstract][Full Text] [Related]
14. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Ferguson JA; Reeves WC; Milby MM; Hardy JL Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386 [TBL] [Abstract][Full Text] [Related]
16. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates. Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163 [TBL] [Abstract][Full Text] [Related]
17. Rapid diagnosis of Venezuelan equine encephalomyelitis by fluorescence microscopy. Erickson GA; Maré CJ Am J Vet Res; 1975 Feb; 36(2):167-70. PubMed ID: 803352 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054 [TBL] [Abstract][Full Text] [Related]
19. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses. Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002 [TBL] [Abstract][Full Text] [Related]
20. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Grieder FB; Vogel SN Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]